Company intelligence / Profile preview

Medtech

Ownership: Private
Development stage: Commercial

Overview

MedTech Barcelona, through its ReadyCell branch, provides innovative cell-based assay kits that enable immediate use upon delivery. Their patented technology allows global shipment of living cells at room temperature, supporting efficient drug discovery workflows by reducing delivery times and simplifying logistics. New ready-to-use cell-based kits are also under development.

Therapeutic areas: Other
Modalities: Cell-based assays/tools for ADME-Tox and DMPK studies (in vitro models)
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Medtech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medtech.

Explore the full profile